Podcast Episodes
Back to Search
Treatment Options for Patients With Multiple Myeloma After First Relapse
Episode 68
In this podcast episode,Charise Gleason, MSN, NP-BC, AOCNP, discusses clinical considerations for patients with multiple myeloma after relapse on ini…
4 years, 9 months ago
Caring for Patients With Newly Diagnosed Multiple Myeloma
Episode 69
In this podcast episode, Beth Faiman, PhD, MSN, APRN-BC, AOCN, discusses clinical considerations for diagnosis and optimal treatment selection for in…
4 years, 9 months ago
Precision Medicine in Gynecologic Cancers: Expert Answers to Your Questions
Episode 67
In this episode, Linda R. Duska, MD, MPH; Robert L. Coleman, MD, FACOG, FACS; and Leslie Randall, MD, MAS, answer questions from an audience of healt…
4 years, 9 months ago
Expert Answers to Questions on Managing Neurofibromatosis Type 1 and MEK Inhibitors for NF1-Associated Plexiform Neurofibromas
Episode 66
In this episode, Scott R. Plotkin, MD, PhD, and Brian D. Weiss, MD, answer questions from a healthcare professional audience on topics related to NF1…
4 years, 9 months ago
Expert Answers to Questions on PARP Inhibitor Combinations in Prostate Cancer
Episode 65
In this episode, Wassim Abida, MD, PhD; Joaquin Mateo, MD, PhD; and Charles J. Ryan, MD, answer questions from an audience of healthcare professiona…
4 years, 9 months ago
Immunotherapy for Advanced HCC: Current Options and Expert Answers to Clinician Questions
Episode 64
In this episode, David Kaplan, MD, MSc, and Thomas Karasic, MD, review approved immunotherapy options for advanced HCC and answer key questions surro…
4 years, 9 months ago
Expert Insight on Key Data From ASCO 2021 Informing Treatment for Endometrial, Ovarian, and Cervical Cancer
Episode 63
In this episode, David Scott Miller, MD, FACOG, FACS, and Melissa M. Hardesty, MD, MPH, provide expert perspectives on new data from ASCO 2021 presen…
4 years, 9 months ago
Optimizing Therapy for Relapsed/Refractory Multiple Myeloma: Expert Answers to Your Questions
Episode 62
In this podcast episode, Suzanne Lentzsch, MD, PhD, and Saad Z. Usmani, MD, MBA, FACP, discuss how they select optimal treatment for relapsed/refrac…
4 years, 9 months ago
Experts Answer FAQs on Biomarker-Driven Therapy for Non-Small-Cell Lung Cancer
Episode 61
In this episode, Nathan Pennell, MD, PhD; Jamie E. Chaft, MD; and Stephen V. Liu, MD, answer questions asked by an audience of healthcare professiona…
4 years, 10 months ago
Congress to Clinic: Post-ELCC Updates on Antibody–Drug Conjugates in NSCLC
Episode 60
In this episode,Egbert F. Smit, MD, PhD; David Planchard, MD, PhD; and Helena A. Yu, MD, answer audience questions from a live webinar regarding cli…
4 years, 10 months ago